Feng Bi

2.3k total citations · 1 hit paper
51 papers, 1.8k citations indexed

About

Feng Bi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feng Bi has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Feng Bi's work include Cancer-related Molecular Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Hippo pathway signaling and YAP/TAZ (7 papers). Feng Bi is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Hippo pathway signaling and YAP/TAZ (7 papers). Feng Bi collaborates with scholars based in China, United States and Chile. Feng Bi's co-authors include Qiulin Tang, Hongwei Xia, Huanji Xu, Yi Zheng, Sheng Zhou, Yan Xue, Xuebiao Yao, Yanglin Pan, Ming Liu and Daiming Fan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Feng Bi

50 papers receiving 1.8k citations

Hit Papers

Cholesterol metabolism: New functions and therapeutic app... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Bi China 25 1.2k 539 354 331 234 51 1.8k
Yichao Zhu China 27 1.2k 1.0× 544 1.0× 380 1.1× 201 0.6× 99 0.4× 92 2.0k
Nicole R. Murray United States 26 1.4k 1.2× 381 0.7× 637 1.8× 273 0.8× 186 0.8× 47 2.1k
Federico Gulluni Italy 16 1.5k 1.3× 333 0.6× 342 1.0× 475 1.4× 141 0.6× 19 2.1k
Gilles Ponzio France 28 1.6k 1.4× 562 1.0× 447 1.3× 342 1.0× 281 1.2× 53 2.3k
Zhimin Lu United States 12 1.8k 1.5× 734 1.4× 394 1.1× 314 0.9× 117 0.5× 13 2.3k
Mohammed Soutto United States 29 1.1k 0.9× 497 0.9× 485 1.4× 240 0.7× 411 1.8× 61 2.0k
Sizhen Gao United States 9 1.4k 1.1× 579 1.1× 372 1.1× 403 1.2× 110 0.5× 9 2.1k
Hyonchol Jang South Korea 25 1.5k 1.2× 520 1.0× 245 0.7× 138 0.4× 141 0.6× 66 1.9k
Leyuan Liu United States 28 1.2k 1.0× 311 0.6× 192 0.5× 353 1.1× 99 0.4× 57 1.9k
Gretchen Argast United States 17 1.1k 0.9× 223 0.4× 357 1.0× 181 0.5× 169 0.7× 26 1.6k

Countries citing papers authored by Feng Bi

Since Specialization
Citations

This map shows the geographic impact of Feng Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Bi more than expected).

Fields of papers citing papers by Feng Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Bi. The network helps show where Feng Bi may publish in the future.

Co-authorship network of co-authors of Feng Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Bi. A scholar is included among the top collaborators of Feng Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Bi. Feng Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Feng, et al.. (2025). Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma. Cancer Medicine. 14(21). e71330–e71330.
2.
Huang, Chen, et al.. (2025). Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma. Cell Biology and Toxicology. 41(1). 35–35. 2 indexed citations
3.
Zhang, Chenyu, Miao Dai, Jun Yang, et al.. (2025). Patient with HR-proficient advanced ovarian cancer achieved a complete response with Cadonilimab combined chemotherapy (PD-1/CTLA-4 bispecific): a case report and literature review. Gynecologic Oncology Reports. 60. 101785–101785. 1 indexed citations
4.
Zhang, Huan, Huanji Xu, Chenliang Zhang, Qiulin Tang, & Feng Bi. (2021). Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis. Cell Death Discovery. 7(1). 207–207. 55 indexed citations
5.
Ye, Di, Huanji Xu, Qiulin Tang, et al.. (2021). The role of 5-HT metabolism in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188618–188618. 34 indexed citations
6.
Xu, Huanji, Hongwei Xia, Sheng Zhou, Qiulin Tang, & Feng Bi. (2021). Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer. Cell Death Discovery. 7(1). 38–38. 22 indexed citations
7.
Xu, Huanji, Sheng Zhou, Qiulin Tang, Hongwei Xia, & Feng Bi. (2020). Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188394–188394. 253 indexed citations breakdown →
8.
Zhou, Sheng, Huanji Xu, Qiulin Tang, Hongwei Xia, & Feng Bi. (2019). Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway. Molecular Cancer Therapeutics. 19(1). 135–146. 35 indexed citations
9.
Xia, Hongwei, Qiulin Tang, Huanji Xu, et al.. (2017). Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. Scientific Reports. 7(1). 40802–40802. 85 indexed citations
10.
Liu, Ming, Zheng Zhang, Leesa Sampson, et al.. (2017). RHOA GTPase Controls YAP-Mediated EREG Signaling in Small Intestinal Stem Cell Maintenance. Stem Cell Reports. 9(6). 1961–1975. 30 indexed citations
11.
Liu, Ming, Feng Bi, Xuan Zhou, & Yi Zheng. (2012). Rho GTPase regulation by miRNAs and covalent modifications. Trends in Cell Biology. 22(7). 365–373. 74 indexed citations
12.
Wang, Zi, Chunmei Huang, Qian Deng, et al.. (2012). Effects of the proapoptotic regulator Bcl-2/adenovirus EIB 19-kDa-interacting protein 3 on the chemosensitivity of human colon cancer cell lines. Oncology Letters. 4(6). 1195–1202. 3 indexed citations
13.
Wang, Zi, Chunmei Huang, Qian Deng, et al.. (2011). Effects of the Proapoptotic Regulator Bcl2/Adenovirus EIB 19 kDa-Interacting Protein 3 on Radiosensitivity of Cervical Cancer. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 279–286. 5 indexed citations
14.
Peng, Xingchen, Fengming Gong, Wei Meng, et al.. (2010). Proteomic analysis of cell lines to identify the irinotecan resistance proteins. Journal of Biosciences. 35(4). 557–564. 7 indexed citations
15.
Zhou, Jitao, Yajie Zhu, Guoyun Zhang, et al.. (2010). A distinct role of RhoB in gastric cancer suppression. International Journal of Cancer. 128(5). 1057–1068. 52 indexed citations
16.
Wang, Fengsong, Peng Xia, Fang Wu, et al.. (2008). Helicobacter pylori VacA Disrupts Apical Membrane-Cytoskeletal Interactions in Gastric Parietal Cells. Journal of Biological Chemistry. 283(39). 26714–26725. 55 indexed citations
17.
Liu, Na, Guoyun Zhang, Feng Bi, et al.. (2007). RhoC is essential for the metastasis of gastric cancer. Journal of Molecular Medicine. 85(10). 1149–1156. 43 indexed citations
18.
Zhang, Wei, Yingjiang Zhou, Zhigang Guo, et al.. (2006). Preparation of Tissue-Specific Monoclonal Antibodies Using Purified Endothelial Membrane Proteins from Biotinylated Pulmonary Vasculature of Rhesus Monkey. Hybridoma. 25(1). 15–19. 1 indexed citations
19.
Zhou, Yingjiang, Jing Zhang, Wei Zhang, et al.. (2005). A novel method to isolate and map endothelial membrane proteins from pulmonary vasculature. American Journal of Physiology-Cell Physiology. 288(4). C950–C956. 14 indexed citations
20.
Bi, Feng, Balázs Debreceni, Kejin Zhu, et al.. (2001). Autoinhibition Mechanism of Proto-Dbl. Molecular and Cellular Biology. 21(5). 1463–1474. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026